Morningstar

BlackRock Health Sciences Opportunities Portfolio Investor A Shares SHSAX

Morningstar Medalist Rating
Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 67.41  /  +1.06 %
  • Total Assets 6.2B
  • Adj. Expense Ratio
    1.090%
  • Expense Ratio 1.090%
  • Distribution Fee Level Below Average
  • Share Class Type Front Load
  • Category Health
  • Investment Style Large Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.26%
  • Turnover 43%

USD | NAV as of Jul 22, 2026 | 1-Day Return as of Jul 22, 2026, 12:50 AM GMT+0

Morningstar’s Analysis SHSAX

Will SHSAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable SHSAX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the SHSAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of SHSAX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BlackRock Health Sciences Opps Inv A holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHSAX

More SHSAX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 53.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.68 788M
Healthcare

Johnson & Johnson

7.87 489M
Healthcare

UnitedHealth Group Inc

6.34 394M
Healthcare

Merck & Co Inc

5.26 327M
Healthcare

AbbVie Inc

5.11 317M
Healthcare

Gilead Sciences Inc

3.74 233M
Healthcare

Amgen Inc

3.44 214M
Healthcare

Thermo Fisher Scientific Inc

3.18 197M
Healthcare

Vertex Pharmaceuticals Inc

2.89 180M
Healthcare

Edwards Lifesciences Corp

2.49 155M
Healthcare

Sponsor Center